Australian hydroxychloroquine trial to treat Covid-19 under review after WHO safety concern
An Australian trial of two experimental drugs to treat Covid-19 is under review after the World Health Organization halted all its trials involving hydroxychloroquine due to concerns about its efficacy and safety.
The board responsible for monitoring the safety of the trial was meeting on Tuesday evening to discuss the future of the study.
On Friday the Lancet published a study that found Covid-19 patients who received hydroxychloroquine were dying at higher rates and experiencing more heart-related complications than other virus patients. The large observational study analysed data from nearly 15,000 patients with Covid-19 who received the drug alone or in combination with antibiotics, comparing this data with 81,000 controls who did not receive the drug.
Read more: https://www.theguardian.com/world/2020/may/26/australian-hydroxychloroquine-trial-under-review-world-health-organization-concern-over-safety

The board responsible for monitoring the safety of the trial was meeting on Tuesday evening to discuss the future of the study.
On Friday the Lancet published a study that found Covid-19 patients who received hydroxychloroquine were dying at higher rates and experiencing more heart-related complications than other virus patients. The large observational study analysed data from nearly 15,000 patients with Covid-19 who received the drug alone or in combination with antibiotics, comparing this data with 81,000 controls who did not receive the drug.
Read more: https://www.theguardian.com/world/2020/may/26/australian-hydroxychloroquine-trial-under-review-world-health-organization-concern-over-safety

Comments
Post a Comment